Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CNSPNASDAQ:ENVBNASDAQ:GRINASDAQ:NEPT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCNSPCNS Pharmaceuticals$1.05-2.3%$1.13$0.77▼$447.00$5.71M2.67685,743 shs100,587 shsENVBEnveric Biosciences$1.17-3.3%$1.28$1.01▼$11.97$2.89M0.68764,281 shs54,015 shsGRIGRI Bio$1.39+1.5%$1.80$1.10▼$81.77$2.98M-1.67307,221 shs75,479 shsNEPTNeptune Wellness Solutions$0.39$0.19▼$28.00$906K2.19462,687 shs2.25 million shsMetaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCNSPCNS Pharmaceuticals0.00%-5.00%-7.52%-52.50%-99.81%ENVBEnveric Biosciences0.00%-8.59%-9.29%-55.00%-90.00%GRIGRI Bio0.00%+15.83%-33.81%-81.81%-97.92%NEPTNeptune Wellness Solutions0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCNSPCNS Pharmaceuticals1.3717 of 5 stars3.32.00.00.02.70.00.0ENVBEnveric Biosciences2.7527 of 5 stars3.54.00.00.02.70.01.3GRIGRI Bio2.9529 of 5 stars3.55.00.00.02.30.01.3NEPTNeptune Wellness SolutionsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCNSPCNS Pharmaceuticals 2.50Moderate Buy$25.002,292.34% UpsideENVBEnveric Biosciences 3.00Buy$10.00754.63% UpsideGRIGRI Bio 3.00Buy$22.001,482.73% UpsideNEPTNeptune Wellness Solutions 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest ENVB, CNSP, GRI, and NEPT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/27/2025GRIGRI BioAscendiant Capital MarketsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$40.00 ➝ $34.005/22/2025CNSPCNS PharmaceuticalsAlliance Global PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy4/14/2025GRIGRI BioHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.003/25/2025CNSPCNS PharmaceuticalsMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold3/6/2025ENVBEnveric BiosciencesHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$10.00 ➝ $10.00(Data available from 6/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCNSPCNS PharmaceuticalsN/AN/AN/AN/A($35.66) per shareN/AENVBEnveric BiosciencesN/AN/AN/AN/A$10.71 per shareN/AGRIGRI BioN/AN/AN/AN/A$5.22 per shareN/ANEPTNeptune Wellness Solutions$52.62M0.00N/AN/A($91.90) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCNSPCNS Pharmaceuticals-$18.85M-$3,748.50N/A∞N/AN/AN/A-515.32%8/12/2025 (Estimated)ENVBEnveric Biosciences-$17.29M-$38.38N/AN/AN/AN/A-221.54%-164.32%8/11/2025 (Estimated)GRIGRI Bio-$13.04M-$11.56N/AN/AN/AN/A-289.05%-165.01%8/12/2025 (Estimated)NEPTNeptune Wellness Solutions-$60.46M-$106.72N/AN/AN/A-128.13%N/A-141.94%N/ALatest ENVB, CNSP, GRI, and NEPT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/15/2025Q1 2025CNSPCNS PharmaceuticalsN/A-$1.58N/A-$1.58N/AN/A5/15/2025Q1 2025GRIGRI Bio-$4.08-$5.80-$1.72-$5.80N/AN/A5/14/2025Q1 2025ENVBEnveric Biosciences-$3.45-$1.22+$2.23-$1.22N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCNSPCNS PharmaceuticalsN/AN/AN/AN/AN/AENVBEnveric BiosciencesN/AN/AN/AN/AN/AGRIGRI Bio$1.91137.41%N/AN/A N/ANEPTNeptune Wellness SolutionsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCNSPCNS PharmaceuticalsN/A1.821.82ENVBEnveric BiosciencesN/A5.175.17GRIGRI BioN/A3.103.10NEPTNeptune Wellness SolutionsN/A0.230.10Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCNSPCNS Pharmaceuticals14.02%ENVBEnveric Biosciences13.82%GRIGRI Bio33.95%NEPTNeptune Wellness Solutions14.44%Insider OwnershipCompanyInsider OwnershipCNSPCNS Pharmaceuticals0.07%ENVBEnveric Biosciences1.10%GRIGRI Bio0.13%NEPTNeptune Wellness Solutions5.10%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCNSPCNS Pharmaceuticals55.46 million57.45 millionNot OptionableENVBEnveric Biosciences202.47 million656,000Not OptionableGRIGRI Bio12.14 million8.92 millionNot OptionableNEPTNeptune Wellness Solutions584.53 million4.30 millionNot OptionableENVB, CNSP, GRI, and NEPT HeadlinesRecent News About These Companiest20 world cup 2020 teamsDecember 28, 2024 | bweducation.businessworld.inNeptune Wellness Solutions Inc. (NEPTF)November 27, 2024 | finance.yahoo.comThree Breakthrough Strategies To Revolutionize Pain Relief And WellnessNovember 7, 2024 | forbes.comThe Aesthetic Experience introduces AE WellnessNovember 7, 2024 | koin.comNeptune homeless camp down to 13 people as deadline to shut it down is nearly hereOctober 18, 2024 | app.comThe Next Era of Lenovo Neptune Water Cooling Arrives to Efficiently Power NVIDIA Blackwell Platform and AI at Every ScaleOctober 15, 2024 | valdostadailytimes.comOpen Letter to Dominican President Luis Abinader: Stop Deportations Now!October 12, 2024 | counterpunch.org2024 Wellness Olympia Results & Prize Money — Isabelle Nunes Wins 1st TitleOctober 12, 2024 | fitnessvolt.comKroger Wellness Festival canceled, products will go to people impacted by HeleneSeptember 28, 2024 | local12.comRestore Hyper Wellness and MECOTEC Announce Strategic Partnership in Cryotherapy SolutionsSeptember 24, 2024 | tmcnet.comCapitol Wellness Solutions opens new medical marijuana dispensary in Baton RougeSeptember 21, 2024 | yahoo.comCapitol Wellness Solutions opened a new medical marijuana dispensary, for the first time in LouisianaSeptember 21, 2024 | msn.comGiant space balloon ‘Spaceship Neptune-Excelsior’ completes 2nd test flight in TitusvilleSeptember 19, 2024 | clickorlando.comSpace Perspective's Spaceship Neptune capsule lifts off from ship on test flightSeptember 16, 2024 | floridatoday.comNeptune Beach, FL Weather ConditionsAugust 30, 2024 | wunderground.comHigh-tech wizardry and old-fashioned care will grow pot indoors at Neptune's GardenAugust 30, 2024 | app.comYour Daily Horoscope: Sunday, August 25, 2024August 25, 2024 | msn.comExploring Alternative Wellness Options for Stress Management & RelaxationAugust 25, 2024 | spacecoastdaily.comSunrise Total Mind Wellness closing its doors in New BraunfelsAugust 18, 2024 | herald-zeitung.comNeptune Medical raises $97M for surgical robotics, spins out Jupiter EndovascularAugust 16, 2024 | therobotreport.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeBullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsBy Thomas Hughes | May 27, 2025View Bullish NVIDIA Market Set to Surge 50% Ahead of Q1 EarningsIntel’s Turnaround May Be the Best Bet No One’s WatchingBy Jeffrey Neal Johnson | May 30, 2025View Intel’s Turnaround May Be the Best Bet No One’s Watching3 Quality Stocks Trading Near 52-Week LowsBy Gabriel Osorio-Mazilli | May 30, 2025View 3 Quality Stocks Trading Near 52-Week LowsCAVA's Explosive Growth Makes It a Must-Watch StockBy Gabriel Osorio-Mazilli | May 19, 2025View CAVA's Explosive Growth Makes It a Must-Watch StockENVB, CNSP, GRI, and NEPT Company DescriptionsCNS Pharmaceuticals NASDAQ:CNSP$1.04 -0.03 (-2.34%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$1.05 +0.01 (+0.48%) As of 05/30/2025 07:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, which completed Phase I clinical trial that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc., Reata Pharmaceuticals, Inc., Pomeranian Medical University, and The University of Texas M.D. Anderson Cancer Center; and a development agreement with WPD Pharmaceuticals Inc. The company was incorporated in 2017 and is based in Houston, Texas.Enveric Biosciences NASDAQ:ENVB$1.17 -0.04 (-3.30%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$1.18 +0.01 (+0.50%) As of 05/30/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.GRI Bio NASDAQ:GRI$1.39 +0.02 (+1.46%) As of 05/30/2025 04:00 PM EasternGRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.Neptune Wellness Solutions NASDAQ:NEPTNeptune Wellness Solutions Inc., a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils. Its custom formulations are available in various delivery forms, such as softgels, liquid solutions, nutritional emulsions, and chewables. Neptune Wellness Solutions Inc. was founded in 1998 and is headquartered in Laval, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/26 - 05/30 Super Micro Computer Stock Finding Upside With NVIDIA's Blackwell Ackman Takes a Swing at Amazon — Should You? Taiwan Semiconductor: Time to Buy After Strong NVIDIA Results? Intel’s Turnaround May Be the Best Bet No One’s Watching Apple’s Quiet HomePad Delay Could Be Its Loudest Move Yet Nike’s Amazon Expansion Could Signal a Turnaround in 2025 ASML Stock Might Be the Safest Chip Play at This Price Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
